The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands.

This information was originally presented at the NCCN 2017 Oncology Fellows Program: New Horizons in Quality Cancer Care™ held on March 26, 2017.

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

The 2015 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of melanoma, biomarkers, management of cancer in older patients with comorbidities, managing symptoms and reducing complications, and two sessions on less common and complex canc

The 2015 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of melanoma, biomarkers, management of cancer in older patients with comorbidities, managing symptoms and reducing complications, and two sessions on less common and complex canc

Join Barbara Burtness, MD and Zain Husain, MD as they present their multidisciplinary expertise on a range of cases pertaining to human papillomavirus (HPV) infection and head and neck (H&N) cancer.

These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Head and Neck (H&N) Cancers.

Join Barbara Burtness, MD and Zain Husain, MD as they present their multidisciplinary expertise on a range of cases pertaining to human papillomavirus (HPV) infection and head and neck (H&N) cancer.

This study examined the benefits of incorporating screening for distress as a routine part of care for patients with head and neck and neurologic cancers in a tertiary cancer center.